Literature DB >> 28391369

Relationship between lamina cribrosa displacement and trans-laminar pressure difference in papilledema.

Javier García-Montesinos1,2, Francisco J Muñoz-Negrete3, Victoria de Juan3, Gema Rebolleda3.   

Abstract

PURPOSE: The purpose of this study was to describe morphological changes in lamina cribrosa (LC), prelaminar tissue thickness (PTT) and Bruch's membrane opening (BMO) in eyes affected by papilledema and correlate them with trans-LC-pressure difference (TLCD).
METHODS: This was a prospective study, including twelve eyes newly diagnosed of papilledema. Eyes underwent scanning with Spectralis-OCT with enhanced depth imaging to compare BMO, anterior LC surface position (LC depth-LCD-) and PTT before and after oedema resolution. Correlation analysis between these parameters and TLCD was performed.
RESULTS: TLCD inversely correlated with LCD at baseline and directly with LC reversal movement after lowering cerebrospinal fluid pressure (CSFP) (ρSpearman: -0.739, p = 0.006; ρSpearman: 0.844, p = 0.001 respectively). At onset, RNFL thickening and BMO were significantly larger in eyes with TLCD > -9.2 mmHg (group 2) compared with TLCD < -9.2 mmHg (group 1) [p = 0.007, p = 0.041 respectively]. A significant RNFL and BMO shrinking were observed, but they were significantly larger in group 2. The magnitude of LC displacement following oedema resolution was significantly larger and in the opposite direction in group 2 vs group 1 (-68.7 μm vs 19.5 μm, p = 0.016). TLCD correlated with RNFL thickening at baseline (ρSpearman: 0.667, p = 0.018) and with RNFL thinning at last visit (ρSpearman: 0.673, p = 0.017). TLCD correlated with mean deviation (MD) (ρSpearman: 0.712, p = 0.014) and visual field index (VFI) (ρSpearman: -0.657, p = 0.028) at onset. MD and VFI were worse in group 2.
CONCLUSIONS: LC position was significantly related to TLCD in papilledema. Eyes with higher TCLD showed significantly larger backward LC movement, BMO shrinking and RNFL thinning after lowering CSFP compared with eyes with lower TLCD, where LC movement occurred in the opposite direction.

Entities:  

Keywords:  Bruch’s membrane opening; Enhanced depth imaging; Lamina cribrosa; Papilledema; Trans-laminar pressure difference

Mesh:

Year:  2017        PMID: 28391369     DOI: 10.1007/s00417-017-3661-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  14 in total

Review 1.  Diagnostic criteria for idiopathic intracranial hypertension.

Authors:  Deborah I Friedman; Daniel M Jacobson
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

2.  Bruch's membrane opening changes and lamina cribrosa displacement in non-arteritic anterior ischaemic optic neuropathy.

Authors:  Gema Rebolleda; Javier García-Montesinos; Elisabet De Dompablo; Noelia Oblanca; Francisco J Muñoz-Negrete; Julio J González-López
Journal:  Br J Ophthalmol       Date:  2016-05-09       Impact factor: 4.638

3.  Pseudotumor cerebri appearing with unilateral papilledema after trabeculectomy.

Authors:  D S Greenfield; B Wanichwecharungruang; J M Liebmann; R Ritch
Journal:  Arch Ophthalmol       Date:  1997-03

4.  Laminar displacement and prelaminar tissue thickness change after glaucoma surgery imaged with optical coherence tomography.

Authors:  Alexandre S C Reis; Neil O'Leary; Miriam J Stanfield; Lesya M Shuba; Marcelo T Nicolela; Balwantray C Chauhan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-24       Impact factor: 4.799

5.  Lamina cribrosa displacement after optic nerve sheath fenestration in idiopathic intracranial hypertension: a new tool for monitoring changes in intracranial pressure?

Authors:  Marta Perez-Lopez; Darren S J Ting; Lucy Clarke
Journal:  Br J Ophthalmol       Date:  2014-08-12       Impact factor: 4.638

6.  Anterior lamina cribrosa surface position in idiopathic intracranial hypertension and glaucoma.

Authors:  Jenni M Villarruel; Xiao Q Li; Daniella Bach-Holm; Steffen Hamann
Journal:  Eur J Ophthalmol       Date:  2016-05-16       Impact factor: 2.597

7.  Effects of lowering cerebrospinal fluid pressure on the shape of the peripapillary retina in intracranial hypertension.

Authors:  Patrick Sibony; Mark J Kupersmith; Robert Honkanen; F James Rohlf; Ali Torab-Parhiz
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-18       Impact factor: 4.799

8.  Reversal of lamina cribrosa displacement and thickness after trabeculectomy in glaucoma.

Authors:  Eun Ji Lee; Tae-Woo Kim; Robert N Weinreb
Journal:  Ophthalmology       Date:  2012-03-29       Impact factor: 12.079

9.  Translaminar pressure in Caucasian normal tension glaucoma patients.

Authors:  Achmed Pircher; Luca Remonda; Robert N Weinreb; Hanspeter E Killer
Journal:  Acta Ophthalmol       Date:  2016-12-14       Impact factor: 3.761

10.  Reversal of lamina cribrosa displacement after intraocular pressure reduction in open-angle glaucoma.

Authors:  Eun Ji Lee; Tae-Woo Kim; Robert N Weinreb; Hyunjoong Kim
Journal:  Ophthalmology       Date:  2012-12-06       Impact factor: 12.079

View more
  4 in total

Review 1.  Intracranial and Intraocular Pressure at the Lamina Cribrosa: Gradient Effects.

Authors:  Gauti Jóhannesson; Anders Eklund; Christina Lindén
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-12       Impact factor: 5.081

2.  Commentary: Assessing the lamina cribrosa in idiopathic intracranial hypertension.

Authors:  Padmaja Sudhakar
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848

3.  Morphological assessment of lamina cribrosa in idiopathic intracranial hypertension.

Authors:  Ipek Tanir Tatar; Banu Solmaz; Zeynep Gizem Erdem; Isıl Pasaoglu; Ali Demircan; Beril Tülü Aygün; Abdullah Ozkaya
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848

Review 4.  Optical Coherence Tomography Neuro-Toolbox for the Diagnosis and Management of Papilledema, Optic Disc Edema, and Pseudopapilledema.

Authors:  Patrick A Sibony; Mark J Kupersmith; Randy H Kardon
Journal:  J Neuroophthalmol       Date:  2021-03-01       Impact factor: 4.415

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.